<DOC>
	<DOCNO>NCT02090504</DOCNO>
	<brief_summary>Benzodiazepines ( BDZs ) gold standard treatment alcohol withdrawal syndrome ( AWS ) . Gamma-Hydroxybutyric acid also know sodium oxybate ( SMO ) test treatment AWS encouraging result . Aim phase IV , multicenter randomize double-blind , double dummy study evaluate efficacy SMO comparison oxazepam treatment alcohol withdrawal symptom ( AWS ) .</brief_summary>
	<brief_title>Comparative Study Gamma-hydroxy Butyrate Versus Oxazepam Treatment Alcohol Withdrawal Syndrome</brief_title>
	<detailed_description>This phase IV , multicenter randomize ( 1:1 ) , active drug-controlled study ( double-blind , double dummy ) parallel group evaluate efficacy SMO versus oxazepam treatment AWS alcohol-dependent patient . A placebo-controlled design consider excluded , give gold standard treatment AWS available ( i.e. , BDZs ) . Furthermore , consider SMO oxazepam two different pharmaceutical formulation ( suspension tablet , respectively ) , double-dummy design adopt . Thus , subject receive medication , tablet ( oxazepam placebo ) suspension ( SMO placebo ) , time .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Substance Withdrawal Syndrome</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Oxazepam</mesh_term>
	<mesh_term>Sodium Oxybate</mesh_term>
	<mesh_term>Butyric Acid</mesh_term>
	<criteria>age range 2175 , diagnosis alcohol dependence accord DSMIV criterion presence AWS assess Clinical Institute Withdrawal Assessment Alcoholrevised ( CIWAAr ) scale , score system quantitative evaluation physical symptom AWS.20 Only subject CIWAAr score equal high 10 ( define moderate severe AWS require pharmacological treatment ) ultimately enrol study . Exclusion criterion : ≤55 kg body weight ; history withdrawal fit within 24 hour prestudy ; history epilepsy epileptic seizure properly control establish antiepileptic treatment ; dependence narcotic , BDZs drug abuse ; document preexistent hypersensitivity SMO BDZs , renal failure ( blood creatinine &gt; 2•5 mg/dl and/or document proteinuria &gt; 500 mg/die ) , heart failure , severe respiratory failure hepatic encephalopathy stage IIIV ; psychiatric disorder require treatment psychoactive medication start study ; treatment clonidine , haloperidol , bromocriptine last 3 month prior participation study ; participation clinical investigation previous month prior recruitment ; female whose could assure become pregnant 1 month period treatment , subsequent 3 week ; subject without stable social condition homeless .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>alcohol withdrawal syndrome</keyword>
	<keyword>treatment</keyword>
	<keyword>sodium oxybate</keyword>
	<keyword>oxazepam</keyword>
</DOC>